Search filters

List of works by Giulio Metro

Acquired Resistance to Afatinib Due to T790M-Positive Squamous Progression in EGFR-Mutant Adenosquamous Lung Carcinoma.

scientific article

Advances on EGFR mutation for lung cancer

scientific article

Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series

scientific article published on 20 June 2016

Aromatase inhibitors in post-menopausal metastatic breast carcinoma

scientific article published on July 2007

Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.

scientific article published on 28 March 2015

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

scientific article

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

scientific article published on 01 December 2019

CT-Guided Percutaneous Trans-scapular Lung Biopsy in the Diagnosis of Peripheral Pulmonary Lesion Nodules of the Superior Lobes Using Large Needles.

scientific article published on 14 August 2017

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

scientific article

Clinical experience with gefitinib: an update

scientific article

Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.

scientific article published on 14 September 2015

Clinical outcome with platinum-based chemotherapy in patients with advanced nonsquamous EGFR wild-type non-small-cell lung cancer segregated according to KRAS mutation status

scientific article published on 17 October 2013

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

scientific article published on 30 May 2020

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs

scientific article published on 07 April 2020

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Detection of <i>EGFR</i> Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

scientific article published on 07 December 2020

Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies

scientific article published on May 2008

Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation

scientific article published on 01 August 2018

Ductal Breast Carcinoma Metastatic to the Stomach Resembling Primary Linitis Plastica in a Male Patient

scientific article published on 23 September 2016

Emerging drugs for small cell lung cancer--an update

scientific article published on 31 January 2012

Emerging drugs for small-cell lung cancer

scientific article published on December 2009

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.

scientific article published on 28 July 2015

Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).

scientific article published on January 2006

Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?

scientific article published on 9 December 2017

Future options for ALK-positive non-small cell lung cancer.

scientific article

Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis

scientific article published on 13 April 2016

How might treatment of ALK-positive non-small cell lung cancer change in the near future?

scientific article published on 18 August 2016

Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

scientific article published on 01 November 2018

Immune checkpoints inhibitors rechallenge in non-small-cell lung cancer: different scenarios with different solutions?

scientific article published on 16 January 2020

Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation

scientific article published on 6 December 2007

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

scientific article published on 01 December 2018

Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review

scientific article published on 07 July 2020

KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer.

scientific article

Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer

scientific article published in August 2017

Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy

scientific article

Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non-Small Cell Lung Cancer Patient

scientific article published on 01 May 2017

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations.

scientific article

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study.

scientific article

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

scientific article

Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland.

scientific article

Melanosis coli or ischaemic colitis? That is the question

scientific article published on 4 September 2015

Non-coding RNAs in lung cancer

scientific article

Optimal management of ALK-positive NSCLC progressing on crizotinib

scientific article published on 6 February 2017

Osimertinib

scientific article published on 01 January 2018

Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer

scientific article

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

scientific article

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

scientific article published on 24 April 2015

Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity.

scientific article published on 08 May 2017

Perspectives on salvage therapy for non-small-cell lung cancer.

scientific article

Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer

scientific article published on 6 October 2015

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.

scientific article published on 22 October 2009

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib

scientific article published on 17 April 2018

Preface on "Emerging treatment options for brain metastases from non-small cell lung cancer".

scientific article published on December 2016

Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice.

scientific article published in July 2009

RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature

scientific article published on 20 May 2020

Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression

scientific article published on 27 February 2019

Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer

scientific article published on February 2013

Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

scientific article published on 01 December 2019

Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient

scientific article published on 01 October 2018

Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantation

scientific article published in January 2003

Supportive care in neurooncology.

scientific article

Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.

scientific article published on 15 March 2016

Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence

scientific article published on 25 April 2017

Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications

scientific article

Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule

scientific article published on March 2008

The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer ⬇️

scientific article published on May 1, 2011

The safety of nivolumab for the treatment of advanced non-small cell lung cancer

scientific article published on 02 December 2016

Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer

scientific article published on 2 November 2009

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

scientific article

Years of sorafenib investigation in advanced non-small cell lung cancer: is there a 'NExUS' linking an unsuccessful treatment and a potentially active one?

scientific article published on December 2012

miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance.

scientific article

Paulina is supported by:

About Paulina

Help